Global Contraceptives Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
1 Market Overview
- 1.1 Product Overview and Scope of Contraceptives Drugs
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Contraceptives Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Long-acting Contraceptives
- 1.3.3 Short-acting Contraceptives
- 1.3.4 Emergency Contraceptives
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Contraceptives Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Hospital
- 1.4.3 Pharmacy
- 1.4.4 Other
- 1.5 Global Contraceptives Drugs Market Size & Forecast
- 1.5.1 Global Contraceptives Drugs Consumption Value (2019 & 2023 & 2030)
- 1.5.2 Global Contraceptives Drugs Sales Quantity (2019-2030)
- 1.5.3 Global Contraceptives Drugs Average Price (2019-2030)
2 Manufacturers Profiles
- 2.1 Bayer
- 2.1.1 Bayer Details
- 2.1.2 Bayer Major Business
- 2.1.3 Bayer Contraceptives Drugs Product and Services
- 2.1.4 Bayer Contraceptives Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Bayer Recent Developments/Updates
- 2.2 Pfizer
- 2.2.1 Pfizer Details
- 2.2.2 Pfizer Major Business
- 2.2.3 Pfizer Contraceptives Drugs Product and Services
- 2.2.4 Pfizer Contraceptives Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Pfizer Recent Developments/Updates
- 2.3 Teva Pharmaceutical
- 2.3.1 Teva Pharmaceutical Details
- 2.3.2 Teva Pharmaceutical Major Business
- 2.3.3 Teva Pharmaceutical Contraceptives Drugs Product and Services
- 2.3.4 Teva Pharmaceutical Contraceptives Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Teva Pharmaceutical Recent Developments/Updates
- 2.4 Merck
- 2.4.1 Merck Details
- 2.4.2 Merck Major Business
- 2.4.3 Merck Contraceptives Drugs Product and Services
- 2.4.4 Merck Contraceptives Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Merck Recent Developments/Updates
- 2.5 Actavis
- 2.5.1 Actavis Details
- 2.5.2 Actavis Major Business
- 2.5.3 Actavis Contraceptives Drugs Product and Services
- 2.5.4 Actavis Contraceptives Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Actavis Recent Developments/Updates
- 2.6 Johnson & Johnson
- 2.6.1 Johnson & Johnson Details
- 2.6.2 Johnson & Johnson Major Business
- 2.6.3 Johnson & Johnson Contraceptives Drugs Product and Services
- 2.6.4 Johnson & Johnson Contraceptives Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 Johnson & Johnson Recent Developments/Updates
- 2.7 Gedeon Richter
- 2.7.1 Gedeon Richter Details
- 2.7.2 Gedeon Richter Major Business
- 2.7.3 Gedeon Richter Contraceptives Drugs Product and Services
- 2.7.4 Gedeon Richter Contraceptives Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 Gedeon Richter Recent Developments/Updates
- 2.8 Novo Nordisk A/S
- 2.8.1 Novo Nordisk A/S Details
- 2.8.2 Novo Nordisk A/S Major Business
- 2.8.3 Novo Nordisk A/S Contraceptives Drugs Product and Services
- 2.8.4 Novo Nordisk A/S Contraceptives Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.8.5 Novo Nordisk A/S Recent Developments/Updates
- 2.9 ZiZhu
- 2.9.1 ZiZhu Details
- 2.9.2 ZiZhu Major Business
- 2.9.3 ZiZhu Contraceptives Drugs Product and Services
- 2.9.4 ZiZhu Contraceptives Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.9.5 ZiZhu Recent Developments/Updates
- 2.10 Baijingyu
- 2.10.1 Baijingyu Details
- 2.10.2 Baijingyu Major Business
- 2.10.3 Baijingyu Contraceptives Drugs Product and Services
- 2.10.4 Baijingyu Contraceptives Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.10.5 Baijingyu Recent Developments/Updates
- 2.11 Huazhong
- 2.11.1 Huazhong Details
- 2.11.2 Huazhong Major Business
- 2.11.3 Huazhong Contraceptives Drugs Product and Services
- 2.11.4 Huazhong Contraceptives Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.11.5 Huazhong Recent Developments/Updates
3 Competitive Environment: Contraceptives Drugs by Manufacturer
- 3.1 Global Contraceptives Drugs Sales Quantity by Manufacturer (2019-2024)
- 3.2 Global Contraceptives Drugs Revenue by Manufacturer (2019-2024)
- 3.3 Global Contraceptives Drugs Average Price by Manufacturer (2019-2024)
- 3.4 Market Share Analysis (2023)
- 3.4.1 Producer Shipments of Contraceptives Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
- 3.4.2 Top 3 Contraceptives Drugs Manufacturer Market Share in 2023
- 3.4.2 Top 6 Contraceptives Drugs Manufacturer Market Share in 2023
- 3.5 Contraceptives Drugs Market: Overall Company Footprint Analysis
- 3.5.1 Contraceptives Drugs Market: Region Footprint
- 3.5.2 Contraceptives Drugs Market: Company Product Type Footprint
- 3.5.3 Contraceptives Drugs Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Contraceptives Drugs Market Size by Region
- 4.1.1 Global Contraceptives Drugs Sales Quantity by Region (2019-2030)
- 4.1.2 Global Contraceptives Drugs Consumption Value by Region (2019-2030)
- 4.1.3 Global Contraceptives Drugs Average Price by Region (2019-2030)
- 4.2 North America Contraceptives Drugs Consumption Value (2019-2030)
- 4.3 Europe Contraceptives Drugs Consumption Value (2019-2030)
- 4.4 Asia-Pacific Contraceptives Drugs Consumption Value (2019-2030)
- 4.5 South America Contraceptives Drugs Consumption Value (2019-2030)
- 4.6 Middle East and Africa Contraceptives Drugs Consumption Value (2019-2030)
5 Market Segment by Type
- 5.1 Global Contraceptives Drugs Sales Quantity by Type (2019-2030)
- 5.2 Global Contraceptives Drugs Consumption Value by Type (2019-2030)
- 5.3 Global Contraceptives Drugs Average Price by Type (2019-2030)
6 Market Segment by Application
- 6.1 Global Contraceptives Drugs Sales Quantity by Application (2019-2030)
- 6.2 Global Contraceptives Drugs Consumption Value by Application (2019-2030)
- 6.3 Global Contraceptives Drugs Average Price by Application (2019-2030)
7 North America
- 7.1 North America Contraceptives Drugs Sales Quantity by Type (2019-2030)
- 7.2 North America Contraceptives Drugs Sales Quantity by Application (2019-2030)
- 7.3 North America Contraceptives Drugs Market Size by Country
- 7.3.1 North America Contraceptives Drugs Sales Quantity by Country (2019-2030)
- 7.3.2 North America Contraceptives Drugs Consumption Value by Country (2019-2030)
- 7.3.3 United States Market Size and Forecast (2019-2030)
- 7.3.4 Canada Market Size and Forecast (2019-2030)
- 7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
- 8.1 Europe Contraceptives Drugs Sales Quantity by Type (2019-2030)
- 8.2 Europe Contraceptives Drugs Sales Quantity by Application (2019-2030)
- 8.3 Europe Contraceptives Drugs Market Size by Country
- 8.3.1 Europe Contraceptives Drugs Sales Quantity by Country (2019-2030)
- 8.3.2 Europe Contraceptives Drugs Consumption Value by Country (2019-2030)
- 8.3.3 Germany Market Size and Forecast (2019-2030)
- 8.3.4 France Market Size and Forecast (2019-2030)
- 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
- 8.3.6 Russia Market Size and Forecast (2019-2030)
- 8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
- 9.1 Asia-Pacific Contraceptives Drugs Sales Quantity by Type (2019-2030)
- 9.2 Asia-Pacific Contraceptives Drugs Sales Quantity by Application (2019-2030)
- 9.3 Asia-Pacific Contraceptives Drugs Market Size by Region
- 9.3.1 Asia-Pacific Contraceptives Drugs Sales Quantity by Region (2019-2030)
- 9.3.2 Asia-Pacific Contraceptives Drugs Consumption Value by Region (2019-2030)
- 9.3.3 China Market Size and Forecast (2019-2030)
- 9.3.4 Japan Market Size and Forecast (2019-2030)
- 9.3.5 Korea Market Size and Forecast (2019-2030)
- 9.3.6 India Market Size and Forecast (2019-2030)
- 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
- 9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
- 10.1 South America Contraceptives Drugs Sales Quantity by Type (2019-2030)
- 10.2 South America Contraceptives Drugs Sales Quantity by Application (2019-2030)
- 10.3 South America Contraceptives Drugs Market Size by Country
- 10.3.1 South America Contraceptives Drugs Sales Quantity by Country (2019-2030)
- 10.3.2 South America Contraceptives Drugs Consumption Value by Country (2019-2030)
- 10.3.3 Brazil Market Size and Forecast (2019-2030)
- 10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
- 11.1 Middle East & Africa Contraceptives Drugs Sales Quantity by Type (2019-2030)
- 11.2 Middle East & Africa Contraceptives Drugs Sales Quantity by Application (2019-2030)
- 11.3 Middle East & Africa Contraceptives Drugs Market Size by Country
- 11.3.1 Middle East & Africa Contraceptives Drugs Sales Quantity by Country (2019-2030)
- 11.3.2 Middle East & Africa Contraceptives Drugs Consumption Value by Country (2019-2030)
- 11.3.3 Turkey Market Size and Forecast (2019-2030)
- 11.3.4 Egypt Market Size and Forecast (2019-2030)
- 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
- 11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
- 12.1 Contraceptives Drugs Market Drivers
- 12.2 Contraceptives Drugs Market Restraints
- 12.3 Contraceptives Drugs Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Contraceptives Drugs and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Contraceptives Drugs
- 13.3 Contraceptives Drugs Production Process
- 13.4 Contraceptives Drugs Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Contraceptives Drugs Typical Distributors
- 14.3 Contraceptives Drugs Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Contraceptives Drugs market size was valued at USD 12810 million in 2023 and is forecast to a readjusted size of USD 19790 million by 2030 with a CAGR of 6.4% during review period.
Contraceptives are a kind of medicine used to prevent unwanted pregnancy. It consists of one or more synthetic female sex hormones. These sex hormones prevent pregnancy by blocking the normal process of ovulation.
The contraceptives market is driven by the increasing awareness and adoption of family planning methods to control population growth and improve maternal and child health. Contraceptives provide individuals with choices for safe and effective birth control, leading to a decline in unintended pregnancies and a healthier reproductive population. Moreover, government initiatives and awareness campaigns aimed at promoting family planning further contribute to market growth. However, challenges include cultural and social barriers, lack of access to contraceptives in certain regions, and potential side effects associated with some contraceptive methods. Addressing these challenges through education, improved access to contraceptives, and the development of innovative and user-friendly contraceptive options will be crucial for sustaining the growth of the contraceptives market.
The Global Info Research report includes an overview of the development of the Contraceptives Drugs industry chain, the market status of Hospital (Long-acting Contraceptives, Short-acting Contraceptives), Pharmacy (Long-acting Contraceptives, Short-acting Contraceptives), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Contraceptives Drugs.
Regionally, the report analyzes the Contraceptives Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Contraceptives Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Contraceptives Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Contraceptives Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Unit), revenue generated, and market share of different by Type (e.g., Long-acting Contraceptives, Short-acting Contraceptives).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Contraceptives Drugs market.
Regional Analysis: The report involves examining the Contraceptives Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Contraceptives Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Contraceptives Drugs:
Company Analysis: Report covers individual Contraceptives Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Contraceptives Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Pharmacy).
Technology Analysis: Report covers specific technologies relevant to Contraceptives Drugs. It assesses the current state, advancements, and potential future developments in Contraceptives Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Contraceptives Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Contraceptives Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Long-acting Contraceptives
Short-acting Contraceptives
Emergency Contraceptives
Market segment by Application
Hospital
Pharmacy
Other
Major players covered
Bayer
Pfizer
Teva Pharmaceutical
Merck
Actavis
Johnson & Johnson
Gedeon Richter
Novo Nordisk A/S
ZiZhu
Baijingyu
Huazhong
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Contraceptives Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Contraceptives Drugs, with price, sales, revenue and global market share of Contraceptives Drugs from 2019 to 2024.
Chapter 3, the Contraceptives Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Contraceptives Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Contraceptives Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Contraceptives Drugs.
Chapter 14 and 15, to describe Contraceptives Drugs sales channel, distributors, customers, research findings and conclusion.